Keros Therapeutics Stock Probability of Future Stock Price Finishing Under 51.86
| KROS Stock | USD 56.58 0.66 1.18% |
Keros |
Keros Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Keros Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Keros Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 151 K. Net Loss for the year was (152.99 M) with loss before overhead, payroll, taxes, and interest of (87.27 M). | |
| Keros Therapeutics currently holds about 215.62 M in cash with (124.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.37. | |
| Keros Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Over 95.0% of the company shares are owned by institutional investors |
Keros Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Keros Stock often depends not only on the future outlook of the current and potential Keros Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Keros Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 29.4 M | |
| Cash And Short Term Investments | 331.1 M |
Keros Therapeutics Technical Analysis
Keros Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Keros Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Keros Therapeutics. In general, you should focus on analyzing Keros Stock price patterns and their correlations with different microeconomic environments and drivers.
Keros Therapeutics Predictive Forecast Models
Keros Therapeutics' time-series forecasting models is one of many Keros Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Keros Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Keros Therapeutics
Checking the ongoing alerts about Keros Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Keros Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| The company reported the previous year's revenue of 151 K. Net Loss for the year was (152.99 M) with loss before overhead, payroll, taxes, and interest of (87.27 M). | |
| Keros Therapeutics currently holds about 215.62 M in cash with (124.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.37. | |
| Keros Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Over 95.0% of the company shares are owned by institutional investors |
Additional Tools for Keros Stock Analysis
When running Keros Therapeutics' price analysis, check to measure Keros Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Keros Therapeutics is operating at the current time. Most of Keros Therapeutics' value examination focuses on studying past and present price action to predict the probability of Keros Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Keros Therapeutics' price. Additionally, you may evaluate how the addition of Keros Therapeutics to your portfolios can decrease your overall portfolio volatility.